Breast-ovarian Cancer, Familial, Susceptibility To, 2; Brovca2

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Breast-ovarian Cancer, Familial, Susceptibility To, 2; Brovca2

BRCA2

View recommended genes panels

Clinical Features

Phenotypes and symptoms related to Breast-ovarian Cancer, Familial, Susceptibility To, 2; Brovca2

Neoplasm
Breast carcinoma
Ovarian neoplasm

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Breast-ovarian Cancer, Familial, Susceptibility To, 2; Brovca2 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
BRCA2. By Molecular Diagnostic Laboratory University of Alberta (Canada). BRCA2 Specificity 100 % Genes 100 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2 Specificity 50 % Genes 100 %
Hereditary High Risk Breast Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN Specificity 15 % Genes 100 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2 Specificity 50 % Genes 100 %
Hereditary High Risk Breast Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN Specificity 15 % Genes 100 %
Hereditary Melanoma Panel. By Baylor Miraca Genetics Laboratories (United States). BRCA2, TP53, CDK4, CDKN2A Specificity 25 % Genes 100 %
Hereditary Prostate Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). BRCA1, BRCA2, TP53, NBN Specificity 25 % Genes 100 %
Hereditary Pancreatic Cancer Panel. By Baylor Miraca Genetics Laboratories (United States). BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDK4, CDKN2A, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, ATM, PMS2, RAD50 Specificity 6 % Genes 100 %

You can get up to 397 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3 MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4 CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS